\n<\/p>\n
According to the\u00a0American Cancer Society, skin cancer is the most common form of cancer. In fact,\u00a0more than 1.5 million people\u00a0were diagnosed with some form of skin cancer in the year 2020 alone. New research found CBD can help treat symptoms from certain skin cancers.<\/p>\n
It\u2019s a serious health condition that is expected to only increase in prevalence going forward, with cases of skin cancer expected to increase as much as 50% around the world between now and 2040. Depending on the type of skin cancer a person has, and how severe it is, many cases of skin cancer are treatable.<\/p>\n
Other skin conditions may be rarer compared to skin cancer and do not receive as much attention, however, they can still be very serious. One such skin condition is scleroderma, which involves inflammation of the skin. Some patients develop skin ulcers as a result of scleroderma.<\/p>\n
Researchers in Italy recently examined CBD topical\u2019s ability to treat skin ulcers, and they found that CBD topicals were more effective compared to conventional treatments. Below is more information about it via a\u00a0NORML news release:<\/p>\n
Modena, Italy:\u00a0<\/strong>The administration of a topical extract preparation of CBD effectively mitigates wound-related pain and promotes the healing of skin ulcers in patients with scleroderma, according to randomized trial\u00a0data\u00a0published in the journal\u00a0Advances in Skin & Wound Care<\/em>.\u00a0Scleroderma\u00a0(a\/k\/a systemic sclerosis) is a rare autoimmune disorder involving the tightening of the skin and the narrowing of blood vessels.<\/p>\n Italian investigators assessed the efficacy of topical CBD oil compared to conventional medications in a group of scleroderma patients with\u00a0digital ulcers\u00a0(skin ulcers of the fingertips). Twenty-five patients were randomly selected to use CBD for one month; the other 20 received conventional therapy.<\/p>\n Subjects in the CBD group experienced greater pain relief and wound healing than did those in the control group. <\/p>\n Authors reported, \u201cAlthough mean wound-related pain NRS [numeric rating scale] scores did not differ between CBD-treated patients and control patients at baseline, their mean scores differed significantly after 1 month.\u201d <\/p>\n Specifically, patients in the treatment group experienced a decrease in pain of 29 percent over the course of the trial, whereas those in the control group only experienced a six percent decrease.<\/p>\n Investigators further acknowledged, \u201cIn terms of DU [digital ulcer] healing, 18 of the 25 patients in the CBD-treated group (72 percent) experienced complete healing by the end of the study. In contrast, complete healing was observed in (only) 6 of the 20 control group participants (30 percent).\u201d<\/p>\n Patients receiving CBD treatment reported \u201cno significant adverse effects\u201d during the study.<\/p>\n \u201cThe present study is the first to report the effectiveness of local CBD treatment in the management of SSc-DUs [systemic sclerosis digital ulcers],\u201d authors\u00a0concluded.\u00a0 <\/p>\n \u201cTopical administration of CBD is a safe, effective, noninvasive tool that is associated with improved wound-related pain, DU healing, and QoL [quality of life] of patients with SSc.\u201d<\/p>\n The topical application of cannabinoids, and of CBD in particular, has demonstrated benefits in the treatment of a variety of skin-related conditions, including\u00a0psoriasis,\u00a0erythema,\u00a0pruritis, and\u00a0acne. <\/p>\n It has also been associated with wound healing in patients with\u00a0refractory leg ulcers\u00a0and with the rare skin blistering disease\u00a0epidermolysis bullosa.<\/p>\n Full text of the study, \u201cTopical cannabidiol in the treatment of digital ulcers in patients with scleroderma: Comparative analysis and literature review,\u201d appears in<\/em>\u00a0Advances in Skin & Wound Care<\/em>.<\/p>\n